[Federal Register Volume 67, Number 179 (Monday, September 16, 2002)]
[Notices]
[Pages 58448-58449]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: C2-19331]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS

38 CFR Part 4

RIN 2900-AF00


Schedule for Rating Disabilities; the Skin

Correction

    In rule document 02-19331 beginning on page 49590 in the issue of 
Wednesday, July 31, 2002 make the following correction:


Sec. 4.118  [Corrected]

    1. On page 49596, the Rate Schedule for 7802 is corrected to read 
as follows:

------------------------------------------------------------------------
                                                                Rating
------------------------------------------------------------------------
7802 Scars, other than head, face, or neck, that are
 superficial and that do not cause limited motion:.........
    Area or areas of 144 square inches (929 sq. cm.) or               10
     greater...............................................
    Note (1): Scars in widely separated areas, as on two or
     more extremities or on anterior and posterior surfaces
     of extremities or trunk, will be separately rated and
     combined in accordance with Sec.   4.25 of this part.
    Note (2): A superficial scar is one not associated with
     underlying soft tissue damage.
------------------------------------------------------------------------

    2. On the same page, the Rate Schedule for 7807, 7808 and 7809 is 
corrected to read as follows:

------------------------------------------------------------------------
                                                                Rating
------------------------------------------------------------------------
7807 American (New World) leishmaniasis (mucocutaneous,
 espundia):
    Rate as disfigurement of the head, face, or neck (DC
     7800), scars (DC's 7801, 7802, 7803, 7804, or 7805),
     or dermatitis (DC 7806), depending upon the
     predominant disability................................
    Note: Evaluate non-cutaneous (visceral) leishmaniasis
     under DC 6301 (visceral leishmaniasis).
7808 Old World leishmaniasis (cutaneous, Oriental sore):
    Rate as disfigurement of the head, face, or neck (DC
     7800), scars (DC's, 7801, 7802, 7803, 7804, or 7805),
     or dermatitis (DC 7806), depending upon the
     predominant disabililty...............................
    Note: Evaluate non-cutaneous (visceral) leishmaniasis
     under DC 6301 (visceral leishmaniasis).
7809 Discoid lupus erythematosus or subacute cutaneous
 lupus erythematosus:
    Rate as disfigurement of the head, face, or neck (DC
     7800), scars (DC's 7801, 7802, 7803, 7804, or 7805),
     or dermatitis (DC 7806), depending upon the
     predominant disability. Do not combine with ratings
     under DC 6350.........................................
------------------------------------------------------------------------

    3. On page 49597, the Rate Schedule for 7811 is corrected to read 
as follows:

------------------------------------------------------------------------
                                                                Rating
------------------------------------------------------------------------
7811 Tuberculosis luposa (lupus vulgaris), active or
 inactive:
    Rate under Sec.  Sec.   4.88c or 4.89, whichever is
     appropriate...........................................
------------------------------------------------------------------------


[[Page 58449]]

    4. On the same page, the Rate Schedule for 7813 is corrected to 
read as follows:

------------------------------------------------------------------------
                                                                Rating
------------------------------------------------------------------------
7813 Dermatophytosis (ringworm: of body, tinea corporis; of
 head, tinea capitis; of feet, tinea pedis; of beard area,
 tinea barbae; of nails, tinea unguium; of inguinal area
 (jock itch), tinea cruris):
    Rate as disfigurement of the head, face, or neck (DC
     7800), scars (DC's 7801, 7802, 7803, 7804, or 7805),
     or dermatitis (DC 7806), depending upon the
     predominant disability................................
------------------------------------------------------------------------

    5. On the same page, the Rate Schedule for 7818, 7819, and 7820 is 
corrected to read as follows:

------------------------------------------------------------------------
                                                                Rating
------------------------------------------------------------------------
7818 Malignant skin neoplasms (other than malignant
 melanoma):
    Rate as disfigurement of the head, face, or neck (DC
     7800), scars (DC's 7801, 7802, 7803, 7804, or 7805),
     or impairment of function.............................
    Note: If a skin malignancy requires therapy that is
     comparable to that used for systemic malignancies,
     i.e., systemic chemotherapy, X-ray therapy more
     extensive than to the skin, or surgery more extensive
     than wide local excision, a 100-percent evaluation
     will be assigned from the date of onset of treatment,
     and will continue, with a mandatory VA examination six
     months following the completion of such antineoplastic
     treatment, and any change in evaluation based upon
     that or any subsequent examination will be subject to
     the provisions of Sec.   3.105(e) of this chapter. If
     there has been no local recurrence or metastasis,
     evaluation will then be made on residuals. If
     treatment is confined to the skin, the provisions for
     a 100-percent evaluation do not apply.
7819 Benign skin neoplasms:
    Rate as disfigurement of the head, face, or neck (DC
     7800), scars (DC's 7801, 7802, 7803, 7804, or 7805),
     or impairment of function.............................
7820 Infections of the skin not listed elsewhere (including
 bacterial, fungal, viral, treponemal and parasitic
 diseases):
    Rate as disfigurement of the head, face, or neck (DC
     7800), scars (DC's 7801, 7802, 7803, 7804, or 7805),
     or dermatitis (DC 7806), depending upon the
     predominant disability................................
------------------------------------------------------------------------

    6. On page 49599, the Rate Schedule for 7833 is corrected to read 
as follows:

------------------------------------------------------------------------
                                                                Rating
------------------------------------------------------------------------
7833 Malignant melanoma:
    Rate as scars (DC's 7801, 7802, 7803, 7804, or 7805),
     disfigurement of the head, face, or neck (DC 7800), or
     impairment of function (under the appropriate body
     system)...............................................
    Note: If a skin malignancy requires therapy that is
     comparable to that used for systemic malignancies,
     i.e., systemic chemotherapy, X-ray therapy more
     extensive than to the skin, or surgery more extensive
     than wide local excision, a 100-percent evaluation
     will be assigned from the date of onset of treatment,
     and will continue, with a mandatory VA examination six
     months following the completion of such antineoplastic
     treatment, and any change in evaluation based upon
     that or any subsequent examination will be subject to
     the provisions of Sec.   3.105(e). If there has been
     no local recurrence or metastasis, evaluation will
     then be made on residuals. If treatment is confined to
     the skin, the provisions for a 100-percent evaluation
     do not apply.
------------------------------------------------------------------------


[FR Doc. C2-19331 Filed 9-13-02; 8:45 am]
BILLING CODE 1505-01-D